EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation

Minjeong Sung, Dae-Hwan Kim, Eun-Gene Sun, Jun-Eul Hwang, Sang-Hee Cho, Ik-Joo Chung, Hyun-Jeong Shim, Woo Kyun Bae

Endocrinology and Metabolism · 2026

DOI: 10.3803/enm.2025.2448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2026. Verfasst von Minjeong Sung und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. Hauptthemen laut MEDLINE: Insulin Resistance, Insulin Receptor Substrate Proteins, Toll-Like Receptor 2, Carrier Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Chonnam National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin resistance (IR) disrupts hepatic glucose and lipid metabolism, contributing to metabolic dysfunction-associated steatotic liver disease (MASLD) and progression to severe liver complications. Galectin-3-binding protein (LGALS3BP) is a secreted glycoprotein implicated in inflammation and metabolic disorders. Elevated LGALS3BP levels are associated with MASLD and type 2 diabetes (T2D), but its role in IR remains unclear.

Methods

LGALS3BP-deficient models were used to investigate its role in IR and inflammation. Glucose metabolism and insulin signaling were assessed in high-fat diet (HFD)-fed mice. Hepatic cell lines were employed to evaluate the direct effects of LGALS3BP on insulin signaling and inflammation. Mechanistic insights were obtained through RNA sequencing, structural modeling, immunoprecipitation, and protein/gene expression analyses.

Results

LGALS3BP deficiency improved insulin sensitivity in HFD-fed mice by enhancing glucose tolerance, lowering serum glucose and insulin, and increasing hepatic insulin signaling, without altering lipid accumulation. In vitro, LGALS3BP deficiency enhanced insulin signaling and suppressed gluconeogenesis, whereas recombinant LGALS3BP impaired insulin signaling and upregulated gluconeogenesis. RNA sequencing revealed activation of Toll-like receptor 2 (TLR2) and nuclear factor-kappa B (NF-κB) pathways by LGALS3BP. Immunoprecipitation confirmed a direct interaction between LGALS3BP and TLR2, leading to inhibitor kappa kinase (IKK)/NF-κB activation and increased insulin receptor substrate-1 (IRS1) serine phosphorylation, a key inhibitory modification in IR. Furthermore, LGALS3BP deficiency attenuated hepatic fibrosis under chronic HFD, accompanied by downregulated inflammatory signaling pathways.

Conclusion

LGALS3BP contributes to IR through inflammatory responses, particularly via TLR2-IKKα/β signaling that regulates IRS1 serine phosphorylation. LGALS3BP deficiency improves insulin sensitivity and reduces inflammation, suggesting that targeting LGALS3BP may represent a potential therapeutic strategy for metabolic disorders such as T2D and MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceInsulin Receptor Substrate ProteinsToll-Like Receptor 2Carrier ProteinsGlycoproteinsAnimalsMiceSignal TransductionPhosphorylationMaleMice, Inbred C57BLHumansDiet, High-FatSerineMice, Knockout

Stichwörter der Autor:innen

I-kappa B kinaseInflammationInsulin receptor substrate-1Insulin resistanceLGALS3BPToll-like receptor 2

Substanzen

Insulin Receptor Substrate ProteinsToll-Like Receptor 2Irs1 protein, mouseTlr2 protein, mouseCarrier ProteinsSerineGlycoproteins

Autor:innen und Institutionen

  • Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea.
  • BioMedical Sciences Graduate Program, Chonnam National University, Hwasun, Korea.
  • National Immunotherapy Innovation Center, Hwasun, Korea.
  • Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. hijhj@jnu.ac.kr.
  • National Immunotherapy Innovation Center, Hwasun, Korea. hijhj@jnu.ac.kr.
  • Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea. drwookyun@jnu.ac.kr.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • Chonnam National University

Zitieren

APA

Sung, M., Kim, D. H., Sun, E. G., Hwang, J. E., Cho, S. H., Chung, I. J., Shim, H. J., & Bae, W. K. (2026). LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2025.2448

Vancouver

Sung M, Kim DH, Sun EG, Hwang JE, Cho SH, Chung IJ, et al. LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation. Endocrinology and Metabolism. 2026. doi:10.3803/enm.2025.2448

BibTeX
@article{Sung2026,
  author = {Sung, Minjeong and Kim, Dae-Hwan and Sun, Eun-Gene and Hwang, Jun-Eul and Cho, Sang-Hee and Chung, Ik-Joo and Shim, Hyun-Jeong and Bae, Woo Kyun},
  title = {LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation},
  journal = {Endocrinology and Metabolism},
  year = {2026},
  doi = {10.3803/enm.2025.2448}
}
Kostenlos starten →